The prognostic role of serum albumin in patients receiving induction chemotherapy for acute myeloid leukemia (AML)

被引：0
|
作者：
Sadrzadeh, Hossein
Brunner, Andrew Mark
Drapkin, Benjamin Jacob
Babirak, Loren
Werner, Lillian
Ballen, Karen K.
Amrein, Philip C.
Attar, Eyal C.
Chen, Yi-Bin Albert
Spitzer, Thomas R.
McAfee, Steven L.
Neuberg, Donna S.
Fathi, Amir Tahmasb
机构：
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6618
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Outcomes in Obese and Overweight Acute Myeloid Leukemia (AML) Patients Receiving Chemotherapy Dosed According to Actual Body Weight
    Gallagher, Erika M.
    Earl, Marc
    Yeh, Jun-Yen
    Kusick, Karissa
    Kruse, Jaclyn
    Swann, Caitlin
    Smith, April
    Davis, Randall
    Advani, Anjali S.
    Kalaycio, Matt
    Copelan, Edward A.
    Sekeres, Mikkael A.
    BLOOD, 2011, 118 (21) : 649 - 649
  • [42] Cost impact of Filgrastim as an adjunct to chemotherapy for patients with acute myeloid leukemia (AML).
    Lu, ZJ
    Luo, R
    Erder, H
    Heil, G
    Ganser, A
    Lechner, K
    Yin, JL
    Szer, J
    Barge, A
    BLOOD, 1996, 88 (10) : 826 - 826
  • [43] Cost impact of filgrastim as an adjunct to chemotherapy for patients with acute myeloid leukemia (AML).
    Lu, ZJ
    Shi, J
    Erder, MH
    Heil, G
    Ganser, A
    Lechner, K
    Yin, JL
    Szer, J
    Barge, A
    BLOOD, 1997, 90 (10) : 314 - 314
  • [44] Prognostic Impact of Clonal Diversity in Acute Myeloid Leukemia (AML) Treated with Intensive Chemotherapy (IC)
    Cerrano, Marco
    Passet, Marie
    Vasseur, Loic
    Hirsch, Pierre
    Thomas, Xavier
    Quentin, Samuel
    Pasanisi, Justine
    Rabian, Florence
    Rahme, Ramy
    Lengline, Etienne
    Raffoux, Emmanuel
    Dhedin, Nathalie
    Sebert, Marie
    Maarek, Odile
    Raimbault, Anna
    Celli-Lebras, Karine
    Ades, Lionel
    Fenaux, Pierre
    Boissel, Nicolas
    Delhommeau, Francois
    Soulier, Jean
    Dombret, Herve
    Clappier, Emmanuelle
    Sujobert, Pierre
    Itzykson, Raphael
    BLOOD, 2019, 134
  • [45] Immune Modulation with Pomalidomide after Induction Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML)
    Montiel-Esparza, Raul
    Knaus, Hanna A.
    Zeidner, Joshua F.
    Vulic, Ante
    Prince, Gabrielle T.
    Smith, B. Douglas
    Levis, Mark J.
    Streicher, Howard
    Karp, Judith E.
    Luznik, Leo
    Gojo, Ivana
    BLOOD, 2015, 126 (23)
  • [46] Difference Outcome of Pediatric Acute Myeloid Leukemia (AML) Treated with More Intensive Induction Chemotherapy
    Yupensuk, N.
    Torchareon, T.
    Poparn, H.
    Chiengthong, K.
    Techavichit, P.
    Lauhasurayotin, S.
    Sosothikul, D.
    Seksarn, P.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S193 - S193
  • [47] Quality of life evaluation in acute leukemia patients receiving induction chemotherapy
    Lymanets, T.
    Skrypnyk, I.
    Maslova, G.
    Gusachenko, I.
    ANNALS OF ONCOLOGY, 2018, 29
  • [48] Time to Abandon the Day 14 Bone Marrow Biopsy in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy
    Branham, Zachery Clint
    Okereke, Chijioke
    Shoukier, Mahran
    Bradshaw, Danielle
    Kolhe, Ravindra
    Jillella, Anand P.
    Kota, Vamsi K.
    BLOOD, 2022, 140 : 8929 - 8929
  • [49] Incidence of CDI and Association with Antibiotics in a Cohort of Patients with Newly Diagnosed Acute Myeloid Leukemia Receiving Induction Chemotherapy
    Jakob, Carolin
    Bauquet, Aurelie
    Buffet, Renaud
    Vehreschild, Maria
    Vehreschild, Janne
    BLOOD, 2020, 136
  • [50] Role of Wnt/β-Catenin Signalling in Acute Myeloid Leukemia (AML) Cell Response to Chemotherapy
    Kamga, Paul Takam
    Cassaro, Adriana
    Dal Collo, Giada
    Adamo, Annalisa
    Gatti, Alessandro
    Carusone, Roberta
    Midolo, Martina
    Di Trapani, Mariano
    Resci, Federica
    Bonifacio, Massimiliano
    Krampera, Mauro
    BLOOD, 2016, 128 (22)
12345